Please select the option that best describes you:
Topics:
Internal Medicine • Rheumatology • Interstitial lung disease • Myositis • Pulmonology • CADM • MDA5
What is your approach to treatment for MDA5 dermatomyositis patients with rapidly progressive ILD?
Cyclophosphamide/tacrolimus and Rituximab have been used in conjunction with steroids in case series.
Answer from: at Academic Institution
Rapidly progressive ILD is a temporal term, describing rapidly declining lung function within weeks (usually defined as 3 months). Therefore, we commonly use this term when the patient is already hospitalized with respiratory failure. The majority of the data stem from Japan and China, where they en...
Sign in or Register to read more